Bone Biologics Corp
BBLGW- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001419554
No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $400.1K in total; no superinvestor holds it.
Other share classesBBLG
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Bone Biologics Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Bone Biologics Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Frelick Jeff | Chief Executive Officer | 17,204 | Jan 21, 2026 | 1 |
| Walsh Deina H | Chief Financial Officer | 15,000 | Jan 21, 2026 | 1 |
| Gagnon Robert E. | Director | – | Jun 6, 2025 | 0 |
| Stroever Bruce | Director | – | Jun 6, 2025 | 0 |
| Angle Siddhesh Rajendra | Director | – | Jun 6, 2025 | 0 |
| Meikle Phillip Terry II | Director | – | Jun 6, 2025 | 0 |
| Lucera Erick | Director | – | Sep 20, 2023 | 0 |
| Hankey Don | Chairman of the Board | 0Indirect | Mar 29, 2023 | 0 |
| Knight Insurance Company, Ltd | 10% Owner | 0Indirect | Mar 29, 2023 | 0 |
| Hankey Capital, LLC | 10% Owner | 7,025,802Indirect | Oct 19, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Walsh Deina HChief Financial Officer | PPurchase | +8.00K | $0.64 | +$5.12K | +114.3%15.0K after | |
| Sep 12, 2023 (view filing) | Sep 11 | 1 day | Frelick JeffChief Executive Officer | PPurchase | +9.50K | $0.69 | +$6.55K | +123.3%17.2K after | |
| Sep 7, 2023 (view filing) | Sep 6 | 1 day | Walsh Deina HChief Financial Officer | PPurchase | +7.00K | $0.7096 | +$4.97K | New position7.00K after | 2 lots |
| Sep 5, 2023 (view filing) | Aug 31 | 5 days | Frelick JeffChief Executive Officer | PPurchase | +7.60K | $0.66 | +$5.02K | +7,307.7%7.70K after |